Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues
Autolus Therapeutics PLC Sponsored ADR (AUTL) had Profit Margin of -95192.15% for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$0.03M |
|
$-27.61M |
|
-- |
|
$0.03M |
|
$75.89M |
|
$-75.86M |
|
$49.72M |
|
$-26.14M |
|
$-26.14M |
|
$-27.61M |
|
$-27.61M |
|
$-27.61M |
|
$-27.61M |
|
$-75.86M |
|
$-73.79M |
|
255.16M |
|
255.16M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$660.93M |
|
$49.55M |
|
$121.80M |
|
$782.73M |
|
$60.74M |
|
$49.63M |
|
$294.66M |
|
$355.40M |
|
$427.32M |
|
$414.95M |
|
$427.32M |
|
266.13M |
|
| Cash Flow Statement Financials | |
$-206.27M |
|
$-394.55M |
|
$589.55M |
|
$240.34M |
|
$228.81M |
|
$-11.53M |
|
$15.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.88 |
|
-- |
|
-- |
|
0.10 |
|
0.12 |
|
-39165.14% |
|
-261597.40% |
|
-261597.40% |
|
-- |
|
-90147.43% |
|
|
Profit Margin |
-95192.15% |
$-228.35M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-6.46% |
|
-6.65% |
|
-3.53% |
|
-5.79% |
|
$1.61 |
|
$-0.89 |
|
$-0.81 |
|